Market
What major breakthrough will Neuralink's N1 implant achieve in paralysis treatment by end of 2025?
2
Resolution / Starting Odds
Restoration of hand movement • 25%
Restoration of leg movement • 25%
Improvement in speech • 25%
Other • 25%
Major medical journals and news outlets
Story
Neuralink's N1 Implant with 1,024 Electrodes Promises Thought-Controlled Interaction at 9.5 BPS for Paralysis Patients
Dec 16, 2024, 09:02 AM
Neuralink's N1 implant is being hailed as a groundbreaking technology that could revolutionize the way individuals with paralysis interact with the world. The coin-sized device integrates 1,024 electrodes across 64 ultra-thin threads, achieving a bandwidth of 9.5 Bits Per Second (BPS), which is approximately 50% of normal human capability. This technology allows users to control computers, play games, and type using only their thoughts. Elon Musk has highlighted the potential of Neuralink to restore full body mobility by transferring signals from the motor cortex past spinal injuries, a feat already demonstrated in animals. The advancements in this field are generating significant interest among investors and researchers, as they explore the implications for technology and medicine, particularly in enhancing human capabilities and treating conditions like paralysis.
View original story
Similar markets
Significant AI integration • 25%
Other • 25%
Achieves full sensory feedback • 25%
Enables multi-device control • 25%
Improved communication for paralyzed patients • 25%
Enhanced mobility for ALS patients • 25%
New treatment for epilepsy • 25%
Other significant milestone • 25%
Communication • 25%
Medical rehabilitation • 25%
Gaming • 25%
Other • 25%
Other major update • 25%
Increased electrode count • 25%
Extended battery life • 25%
New software features • 25%
No • 50%
Yes • 50%
Parkinson's disease • 25%
Other condition • 25%
Depression • 25%
Epilepsy • 25%
Blindness treatment • 25%
ALS treatment • 25%
Paralysis treatment • 25%
Other breakthrough • 25%
Case study on ALS treatment • 25%
Case study on other neurological conditions • 25%
No high-profile case study • 25%
Case study on paralysis treatment • 25%